|

Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1

Indications

  • Kidney Ischemia1
  • Kidney Failure1
  • Kidney Tumor1
  • Kidney Transplant Rejection1
  • End Stage Renal Disease With Renal Transplant1

Other1 trial

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.